(0.00%) 5 213.75 points
(0.04%) 39 044 points
(-0.02%) 18 195 points
(-1.35%) $77.32
(1.63%) $2.24
(-0.24%) $2 318.70
(-0.54%) $27.40
(-1.26%) $975.90
(0.06%) $0.930
(0.26%) $10.93
(0.14%) $0.801
(0.36%) $91.77
Q1/2024
Generated By Getagraph.com: 2024-03-31
Encompass Health Corp [EHC]
1.62% $ 85.88
Exchange: NYSE Sector: Healthcare Industry: Medical Care Facilities
This document provides a summary of the financial results for Encompass Health Corp (NYSE: EHC) for the first quarter of the calendar year 2024.
Encompass Health Corp, listed on the NYSE under the ticker symbol EHC, operates within the Healthcare sector, focusing on Medical Care Facilities. For the first quarter of 2024, the company has reported strong financial results demonstrating its operational efficiency and stability in the market.
In Q1 2024, Encompass Health reported a revenue of $1.32 billion, reflecting a slight decrease from previous quarters. The company achieved a net income of $112.5 million, which translates to a basic earnings per share (EPS) of $1.13 and a diluted EPS of $1.10. Encompass Health maintained a gross profit of $386.5 million with a gross profit margin of 29.37%, underscoring consistent profitability in its core operations.
The operating income of the company was noted at $140.1 million, reflecting an operating margin of 10.65%. This indicates effective management of operating costs. Additionally, the EBITDA was reported at $256.3 million, resulting in an EBITDA margin of 19.48%, which emphasizes the company's operational efficiency.
The total assets were valued at $6.23 billion, with net debt at approximately $2.79 billion, showcasing a stable financial structure and manageable debt levels. Total equity was reported at $2.36 billion, indicating a strong balance sheet.
As of this report, the market capitalization of Encompass Health stands at $8.29 billion. The company holds an Altman Z-score of 2.54, suggesting a moderate risk of bankruptcy, and a Piotroski score of 7, indicating robust financial health.
Comparatively, Encompass Health has shown excellence with a trailing twelve months (TTM) gross profit margin of 75.77% and an operating profit margin of 12.61%. Its net profit margin TTM was recorded at 7.33%, aligning favorably within industry averages and benchmarks.
The Q1 2024 financial results for Encompass Health Corp reflect a financially stable entity with proficient management and effective operational strategies. With a solid position in the competitive medical care facilities sector, attention to cost management and operational efficiencies will further propel profitability in subsequent quarters.
For more in-depth financial figures and analyses, stakeholders are encouraged to review the comprehensive financial statements and disclosures available on the SEC website.
Revenues Q1 - 2024
Revenue | Gross Profit | Operating Expenses | Interest Expense | EBITDA | Net Income | EPS |
---|---|---|---|---|---|---|
$1.32B | $257.70M" | $50.20M | $35.20M | $277.80M | $112.50M | $1.120 |
Balance Q1 - 2024
Net Income | Depreciation and Amortization | Stock Based Compensation | Change in Working Capital | Net Cash Provided by Operating Activities | Capital Expenditure | Free Cash Flow |
---|---|---|---|---|---|---|
$113.00M | $70.30M | $9.30M | $-1.60M | $238.80M | $-139.40M | $99.40M |